Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry
Authors:
- Vivien M. HsuVHVivien M. Hsu
- Lorinda ChungLCLorinda Chung
- Laura K. HummersLHLaura K. Hummers
- Ami ShahASAmi Shah
- Robert SimmsRSRobert Simms
- Marcy BolsterMBMarcy Bolster
- Faye N. HantFHFaye N. Hant
- Richard M. SilverRSRichard M. Silver
- Aryeh FischerAFAryeh Fischer
- Monique E. HinchcliffMHMonique E. Hinchcliff
- John VargaJVJohn Varga
- Avram Z. GoldbergAGAvram Z. Goldberg
- 1 October 2018
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 46 (2) , 176-183
Abstract
Objective.: We sought to identify predictors of mortality and cardiopulmonary hospitalizations in patients at risk for pulmonary hypertension (PH) and enrolled in PHAROS, a prospective cohort study to investigate the natural history of PH in systemic sclerosis (SSc).Methods.: The at-risk population for PH was defined by the following entry criteria: echocardiogram systolic pulmonary arterial pressure > 40 mmHg, or DLCO < 55% predicted or ratio of % forced vital capacity/%DLCO > 1.6, measured by pulmonary function testing. Baseline clinical measures were evaluated as predictors of hospitalization and death between 2005 and 2014. Cox proportional hazards models were censored at date of PH onset or latest study visit and adjusted for age, sex, race, and disease duration.Results.: Of the 236 at-risk subjects who were followed for a median of 4 years (range 0.4–8.5 yrs), 35 developed PH after entering PHAROS (reclassified as PH group). In the at-risk group, higher mortality was strongly associated with male sex, low %DLCO, exercise oxygen desaturation, anemia, abnormal dyspnea scores, and baseline pericardial effusion. Risks for cardiopulmonary hospitalization were associated with increased dyspnea and pericardial effusions, although PH patients with DLCO < 50% had the highest risk of cardiopulmonary hospitalizations.Conclusion.: Risk factors for poor outcome in patients with SSc who are at risk for PH were similar to others with SSc-PH and SSc-pulmonary arterial hypertension, including male sex, DLCO < 50%, exercise oxygen desaturation, and pericardial effusions. This group should undergo right heart catheterization and receive appropriate intervention if PH is confirmed.Keywords
This publication has 28 references indexed in Scilit:
- Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresAnnals of the Rheumatic Diseases, 2011
- Survival in scleroderma: results from the population‐based South Australian RegisterInternal Medicine Journal, 2011
- Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung diseaseArthritis & Rheumatism, 2009
- Outcome measures for heart involvement in systemic sclerosisRheumatology, 2008
- Changes in causes of death in systemic sclerosis, 1972–2002Annals of the Rheumatic Diseases, 2007
- Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approachAnnals of the Rheumatic Diseases, 2003
- TIME-DEPENDENT COVARIATES IN THE COX PROPORTIONAL-HAZARDS REGRESSION MODELAnnual Review of Public Health, 1999
- The value of the health assessment questionnaire and special patient‐generated scales to demonstrate change in systemic sclerosis patients over timeArthritis & Rheumatism, 1997
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980